Equities
Schweizer SMI startet mit 15 von 20 Titeln im Plus – Givaudan führt Blue Chips an
Der SMI erholt sich nach Wochenverlust und zeigt sich dynamisch am Montagmorgen, während Technologie- und Gesundheitssektor besonders stark performen.
AI Stock-Picking Strategy Delivers +77%, +35%, +29% YTD Returns
An AI-driven investing model has posted nearly 199% returns since its November 2023 launch, outpacing the S&P 500 by 118 percentage points, with Energy Elite, Mid-Cap Movers and Small-Cap Sprinters leading the way.
SMI Index Effect Fails for Galderma, Sandoz as Myth Persists
Two pharmaceutical firms gain SMI inclusion but fail to benefit from the expected index premium, undermining long-held market assumptions.
Crown Castle Sees 2026 Growth Rebound Amid Structural Shifts
Organic growth is projected at 3.6% in 2026, excluding Sprint attrition, as the tower company focuses on consulting and AI-driven infrastructure services.
SAB Bio’s SAFEGUARD Trial Progress and T1D Expansion Strategy Highlighted at Citi Summit
SAB Biotherapeutics outlines clinical milestones for its SAB-142 candidate and a broader Type 1 diabetes (T1D) market opportunity, while emphasizing manufacturing scalability and a strategic field launch.
Avio Posts H1 2026 Growth Amid Stock Decline
Revenue up 18% to EUR 279.7m, EBITDA rises to EUR 12m as backlog exceeds EUR 2bn; U.S. expansion and private equity funding drive expansion plans.
Omnicom Reports 2026 Revenue Guidance Rise Amid Media Integration Progress
Omnicom Group raised its 2026 organic revenue growth outlook to 4.5%-5.0% as its media integration with Interpublic Group progresses, though advertising integration faces challenges and headcount cuts accelerate.
Kymera Therapeutics Raises Oral Immunology Ambitions at Citigroup Summit
Kymera Therapeutics highlighted progress in its oral immunology pipeline, targeting atopic dermatitis and autoimmune diseases, amid a 2.5% stock rise to $118.36.
Navan Raises FY2027 Revenue Guidance to 32% as AI-Driven Growth Accelerates
Navan’s AI-powered travel platform highlights record bookings and gross margins of 75% amid a $4B TBY revenue run, with BoomPop acquisition on track for profitability contributions.
Chemed CEO Highlights Vitas Growth Amid Roto-Rooter Challenges at Jefferies Conference
Chemed Corporation’s hospice business Vitas outperformed expectations, generating over $35 million in Medicare cap cushion, while Roto-Rooter’s plumbing segment faces margin pressures from Google algorithm shifts and rising paid-lead costs.
SL Green Reports Leasing Surge Boosts 2026 Outlook Amid NYC Office Demand
SL Green Realty Corp. highlighted a strong year-to-date leasing performance, exceeding targets and signaling robust demand for office space in New York City.
Groupe Dynamite Posts Q2 2026 Record Margins on Luxury-Focused Shift
Revenue surged 29.8% YoY while adjusted EBITDA margin hit 44.3%, the highest since IFRS adoption, as the retailer expands its premium brand portfolio.
Beowulf Mining's £4.3m fundraising blocked by Swedish FDI review
Sweden's strategic products inspectorate has opened a Foreign Direct Investment review of Beowulf Mining's £4.3m financing, potentially delaying the deal by up to six months and intensifying the miner's cash crunch.
Barclays Sees UK Equities at 20% P/B Discount Amid M&A Boom
UK equities trade at a 20% price-to-book discount and face heightened M&A activity, despite investor outflows, as Barclays highlights sector-specific attractiveness.
European stocks retreat on AI safety concerns, Fed rate bets dampen gains
European indices decline as AI sector stocks falter amid regulatory uncertainty, while oil prices rise on geopolitical tensions and Fed rate hike expectations weigh on risk appetite.
Veeva AI Push Accelerates Amid 2026 Growth Momentum
Veeva Systems highlights AI-driven innovations and revenue growth in life sciences software, with 98% of revenue tied to vertical solutions.
Ingersoll Rand Sees Demand Recovery in Industrial Compressors Amid Geopolitical Shifts
Company highlights improved order trends in North America and China, while restructuring and pricing pressures continue to shape earnings outlook.
Frankfurt Stocks Edge Higher Ahead of US Rate Decision
Germany's Dax rose 0.17% to 25,450 as investors awaited the Federal Reserve's rate decision Wednesday, with AI-themed shares leading gains.
Qorvo Stock Reaches 52-Week High at $109.87
Semiconductor firm Qorvo Inc. hit a key milestone with its stock trading near a 52-week high amid investor optimism.
Applied Nutrition Plc Executives Plan Secondary Share Sale
London-based Applied Nutrition plc’s CEO and COO plan to sell around 6 million shares via an accelerated bookbuild, reducing their combined stake by roughly 2.4% of issued capital.
NCLH Stock Drops to $14.53, 52-Week Low Amid Guidance Cuts
Norwegian Cruise Line Holdings Ltd’s share price fell to a 52-week low of $14.53 amid downward revisions to full-year yield guidance and mixed analyst reactions.
FingerMotion Secures 9.9 MW Power Site in Alberta’s Newell County
The company plans to develop a modular data center hub with behind-the-meter power generation, supported by BlueFlare Group Holdings.
Frasers Group seeks additional seat on Hugo Boss board after takeover
Frasers Group agreed that Hugo Boss chairman Stephan Sturm will step down, allowing the retailer to add Robert Palmer to the German fashion house’s supervisory board. Michael Murray already sits on the board following Frasers’ completed voluntary takeover.
UIL Limited reports 10.8% NAV gain in August
UIL Limited's net asset value (NAV) total return rose 10.8% in August, outperforming the FTSE All Share Total Return Index by 10.1%.